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Background & aims: Postoperative hyperglycaemia is common in patients having major surgery and is
associated with adverse outcomes. This study aimed to determine whether bacteraemia contributed to
postoperative systemic inﬂammation, and whether increases in the expression of muscle mRNAs and
proteins reﬂecting increased muscle inﬂammation, atrophy and impaired carbohydrate oxidation were
evident at the time of surgery, and both local and distant to the site of trauma, and could be associated
with impaired glucoregulation.
Methods: Fifteen adult patients without diabetes undergoing major abdominal surgery participated in
this observational study set in a university teaching hospital. Arterialised-venous blood samples and
muscle biopsies were obtained before and after major elective abdominal surgery, from sites local (rectus
abdominis e RA) and remote to the site of surgery (vastus lateralis e VL). The main outcome measures
included blood glucose concentrations, gut permeability and changes in expression of muscle mRNAs
and proteins linked to inﬂammation and glucose regulation.
Results: Immediately postoperatively, RA demonstrated markedly increased mRNA expression levels of
cathepsin-L (7.5-fold, P < 0.05), FOXO1 (10.5-fold, P < 0.05), MAFbx (11.5-fold, P < 0.01), PDK4 (7.8-fold,
P < 0.05), TNF-a (16.5-fold, P < 0.05) and IL-6 (1058-fold, P < 0.001). A similar, albeit blunted, response
was observed in VL. Surgery also increased expression of proteins linked to inﬂammation (IL-6; 6-fold,
P < 0.01), protein degradation (MAFbx; 4.5-fold, P < 0.5), and blunted carbohydrate oxidation (PDK4;
4-fold, P < 0.05) in RA but not VL. Increased systemic inﬂammation (TNF-a, P < 0.05; IL-6, P < 0.001), and
impaired postoperative glucose tolerance (P < 0.001), but not bacteraemia (although gut permeability
was increased signiﬁcantly, P < 0.05) or increased plasma cortisol, were noted 48 h postoperatively.
Conclusions: A systemic postoperative proinﬂammatory response was accompanied by muscle inﬂam-
mation and metabolic dysregulation both local and remote to the site of surgery, and was not accom-
panied by bacteraemia.
Clinical trial registration: Registered at http://clinicaltrials.gov (NCT01134809).
© 2017 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).id; FOXO, forkhead box O; IL, interleukin; IR, insulin resistance; IRS1, insulin receptor substrate 1; LPS, lipopolysac-
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Skeletal muscle is the primary site for insulin-dependent
glucose uptake [1], and along with the liver, plays an important
role in the development of insulin resistance (IR) and hyper-
glycaemia during states of metabolic stress. One of the hallmarks of
the response to trauma is the development of whole-body IR,
which is proportional to themagnitude of injury [2]. IR is associated
with raised blood glucose concentrations, and linked to this,
increased risk of complications, particularly infectious ones,
impaired wound healing, and delayed discharge from the hospital.
The metabolic response to major surgery, like that to trauma,
starts as a local response, and evolves into a systemic one. The ef-
fectors of the systemic response are complexand involve interactions
between cytokines, neurohormonal mediators and muscle. This
metabolic response to major surgery may be exacerbated further by
inﬂammation-related changes in gut permeability and resultant
bacterial translocation [3]. Furthermore, it is unclear to what extent
the effects of surgical stress at the site of the incision (e.g. abdominal
muscles) are mirrored in tissues distant from the site of the injury
(e.g. lower limb muscles). Signiﬁcantly increased expression of
interleukin-6 (IL-6), IL-6 receptor and tumour necrosis factor a (TNF-
a)mRNAhasbeendemonstrated in skeletalmuscle local to the site of
injury in non-septic post-surgery patients [4], but whether these
gene transcript changes are accompanied by increases at the protein
level and with metabolic dysregulation is unknown.
The reduction of muscle phosphotidyl inositol 3-kinase/protein
kinase B (PI3K/Akt1) phosphorylation, ensuing the activation of
downstream forkhead box O (FOXO) transcription factors, resulted
in a simultaneous induction of muscle atrophy response and
impairment of muscle carbohydrate oxidation within 24 h of lipo-
polysaccharide (LPS) infusion in a rodent model of clinical endo-
toxaemia [5]. Importantly, these events were accompanied by
marked upregulation of FOXO downstream gene targets, including
muscle atrophy F-box (MAFbx), muscle-RING ﬁnger 1 (MuRF1; a
muscle speciﬁc E3-ligase that has been proposed to be a prereq-
uisite for proteasome mediated proteolysis [6,7]) and pyruvate
dehydrogenase kinase-4 (PDK4) that phosphorylates and in-
activates pyruvate dehydrogenase complex (PDC), the rate-limiting
step in carbohydrate oxidation [8,9]. Collectively, these data point
to a role for Akt/FOXO signalling in the simultaneous induction of
muscle atrophy and impairment of muscle carbohydrate oxidation
during endotoxaemia. This suggestionwas further substantiated by
the observation that low-dose dexamethasone infusion, or perox-
isome proliferator-activated receptor g (PPARg) agonism, during
endotoxaemia both dampen muscle inﬂammation and cytokine-
mediated upregulation of Akt/FOXO signalling, thereby reducing
muscle atrophy and the impairment of carbohydrate oxidation in a
rodent model of clinical endotoxaemia [10,11].
In the context of this background, the aims of this observational
study in patients undergoing major abdominal surgery were to
determine whether:
(i) in addition to surgical trauma, bacteraemia secondary to
altered gut permeability following major abdominal surgery
contributed to post-operative systemic inﬂammation.
(ii) increases in the expression of muscle mRNAs and proteins
representing muscle inﬂammation and activation of muscle
protein degradation and inhibition of muscle carbohydrate
oxidation, and previously observed in rodent model of clin-
ical endotoxaemia [10,12], were evident at the time of major
abdominal surgery both local [rectus abdominis (RA)muscle]
and distant [vastus lateralis (VL) muscle] to the site of sur-
gical trauma, and were associated with impaired glucor-
egulation 48 h later.Please cite this article in press as: Varadhan KK, et al., Inﬂammation-med
major abdominal surgery, Clinical Nutrition (2017), https://doi.org/10.1012. Methods
2.1. Participants
Fifteen participants undergoing major elective open abdominal
surgery were studied, following national research ethics service
approval and informed written consent. The protocol was regis-
tered at http://clinicaltrials.gov (NCT01134809). Haemoglobin,
blood urea and electrolytes, and liver function tests were assayed at
screening. Exclusion criteria included emergency surgery, liver
surgery, chronic illness (e.g. diabetes mellitus), disseminated ma-
lignant disease, and medications known to affect glucose meta-
bolism, statins, and chronic use of antibiotics, anti-inﬂammatory
drugs, or immunosuppressive agents.
2.2. Protocol
Arterialised-venous blood samples obtained in the fasted state
at the preassessment visit (screening), immediately before surgery,
at the end of surgery and 48 h postoperatively were analysed for
plasma concentrations of insulin, cytokines (IL-6 and TNF-a),
cortisol and free fatty acid (FFA).
At the beginning and end of surgery, a biopsy was obtained from
RAmuscle from the area of the laparotomywound, and from the VL
muscle using a percutaneous conchotome. The VL specimens ob-
tained at the end of surgery were from the contralateral limb. All
muscle samples were stored in liquid nitrogen until analysis.
Glucose tolerance was assessed during the screening visit and
48 h postoperatively. On each occasion, a venous blood sample was
obtained before (fasting) and 2 h following ingestion of 75 g of
glucose (post-prandial).
A 51Cr-EDTA gut permeability test was performed during the
screening visit and 48 h postoperatively using an oral preparation
containing 1.8 MBq of 51Cr labelled EDTA (GE Healthcare, Amer-
sham, UK) in 100 ml of water. The patients were not allowed to eat
or drink for the next 2 h. Twenty-four-hour urine samples were
collected during the screening visit and 48 h postoperatively for the
51Cr-EDTA tests. Whole blood samples collected 48 h post-
operatively were used to determined levels of bacterial DNA.
2.3. Analyses
2.3.1. Blood glucose and plasma insulin and free fatty acid
concentrations
Whole blood glucose concentrations were determined using a
HemoCue analyser (HemoCue AB, €Angelholm, Sweden), plasma
insulin concentrations using an enzyme-linked immunosorbent
assay (ELISA; Mercodia, Uppsala, Sweden), and plasma FFA con-
centrations using a NEFA-HR (2) R2 WAKO kit (Wako Chemicals
GmbH, Germany) according to the manufacturer's instructions.
2.3.2. Plasma cytokine and cortisol concentrations and blood
bacterial DNA expression
Plasma IL-6, TNF-a and cortisol concentrations were determined
using ELISA quantikine kits (R&D Systems, Minneapolis, USA) ac-
cording to the manufacturer's recommendations.
Total blood DNA was isolated using a Qiagen DNeasy (Valencia,
CA, USA) kit according to themanufacturer's recommendations. DNA
was then quantiﬁed and used to identify levels of bacterial 16S rDNA
using Taqman qPCR with the following nucleotide sequences: For-
wardprimer: 50-AACTGGAGGAAGGTGGGGAT-30; Reverseprimer: 50-
AGGAGGTGATCCAACCGCA-30 and TaqMan probe: 50-(6-FAM)-
TACAAGGCCCGGGAACGTATTCACCG-(TAMRA)-30. The captured
sequence covered a 380-bp amplicon, which resides within the
highly conserved C8 and C9 regions of the bacterial 16S rDNA targetiated muscle metabolic dysregulation local and remote to the site of
6/j.clnu.2017.10.020
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positive wild-type strain SG38 of Bacillus subtilis, which is found in
the gastrointestinal tract of humans.
2.3.3. Gut permeability
Urine samples were analysed in triplicate for 51Cr-EDTA radio-
activity using a g-scintillation counter along with an appropriate
standard. Results were expressed as the percentage urinary
excretion of the orally administered dose of 51Cr-EDTA after
correction for background radioactivity and radioactive decay.
2.3.4. Glycogen and lactate content in rectus abdominis and vastus
lateralis muscles
A portion of each frozen RA and VL muscle sample was freeze-
dried, and following the removal of all visible blood and connec-
tive tissue, was powdered. Muscle metabolites were extracted from
4 to 6 mg of muscle powder in 0.5 mmol/L perchloric acid (PCA,
containing 1 mmol/L EDTA) and the following centrifugation, ex-
tracts were neutralised with 2.2 mmol/L KHCO3. Neutralised PCA
extracts were also used to determinemuscle lactate content using a
modiﬁed spectrophotometric version of the method of Harris et al.
[14] to accommodate the use of a plate reader. Additionally, 1 to
2 mg of freeze-dried muscle was alkaline extracted and muscle
glycogen content was determined spectrophotometrically [14].
2.3.5. Targeted mRNA expression levels in rectus abdominis and
vastus lateralis muscles
mRNA expression of a selection of genes intimately linked to
inﬂammation (IL-6, TNF-a), muscle protein degradation [ubiquitin
E3-ligases, MaFbx and MURF1, cathepsin (CSTL1)], muscle growth
(myostatin, or growth differentiation factor 8 MSTN) and insulin
signalling and carbohydrate oxidation (insulin receptor substrate 1,
IRS1; serineethreonine protein kinase B, AKT1; Forkhead Box O1,
FOXO1; and pyruvate dehydrogenase kinase isoform 4, PDK4) was
determined in RA and VL muscles.
Total RNA was extracted from approximately 25 mg of wet RA
and VL muscle using Tri Reagent (Ambion, Fisher Scientiﬁc,
Loughborough, UK), and subsequently quantiﬁed spectrophoto-
metrically at 260 nmwith RNA purity being determined as the ratio
of 260/280 nm readings. Thereafter, ﬁrst strand cDNA synthesis was
carried out according to previous methodology [15]. mRNA
expression levels of the targeted transcripts were determined using
TaqMan PCR (ABI prism 7900HT sequence detector, Applied Bio-
systems, Warrington, UK), with 2 ml of cDNA, 18 mM of each primer,
and 5 mM probe and Universal TaqMan 2 PCR Mastermix (Applied
Biosystems, Warrington, UK). Each sample was run in duplicate.
Primers andMGB TaqMan probes (Applied Biosystems,Warrington,
UK) were designed such that probes spanned over exoneexon
boundaries to avoid genomic ampliﬁcation. Hydroxymethylbilane
synthase (HMBS) was used as an internal control, and all genes of
interest were labelled with the ﬂuorescent reporter 5-FAM (5-
Carboxyﬂuorescein). The thermal cycling conditions used were:
2 min at 50 C, 10 min at 95 C, followed by 40 cycles at 95 C for
15 s and 60 C for 1 min.
2.3.6. Targeted protein expression levels in rectus abdominis and
vastus lateralis muscles
Proteins expression levels of IL-6, MaFbx, p70S6 kinase, FOXO1
and PDK4 were determined in RA and VL muscle by Western
blotting. A portion of frozen wet muscle was homogenised in Tris
buffer (Tris 50 mM/EDTA 1 mM pH 7.5) that included protease and
phosphatase inhibitors (SigmaeAldrich, St Louis, Missouri, USA).
After homogenisation, each muscle extract was centrifuged for
15 min at 10,000 g. The supernatant was collected and stored
at 80 C for further protein immunoblotting [15]. ProteinPlease cite this article in press as: Varadhan KK, et al., Inﬂammation-med
major abdominal surgery, Clinical Nutrition (2017), https://doi.org/10.101concentration was measured using the Bradford assay. Protein
samples were run on a 4e12% BiseTris acrylamide gel (Invitrogen,
Carlsbad, CA, USA) for 2 h at constant 200 V and transferred to a
polyvinylidene diﬂuoride membrane (PVDF) overnight (at a con-
stant 100 mA), in ice-cold buffers (4 C). The protein transfer was
checked with Ponceau S red staining, before blocking the mem-
brane in BSA, TBS, and Tween for 1 h at room temperature. Mem-
branes were probed with the primary antibody overnight at 4 C.
Antibodies used [phosphorylated (Ser256 PFOXO1) and total FOXO1,
phosphorylated p70 ribosomal S6 kinase (Thr389 Pp70S6k)
(Pp70S6k) and total p70S6k (p70S6k), IL-6 and a-actin] were ob-
tained from Cell Signaling Technology (Danvers, MA, USA). MAFbx,
produced in-house by Pﬁzer Inc. (USA), and PDK4 produced in-
house by AstraZeneca (UK), were provided as gifts. Membranes
were washed with TBS-T and incubated with the appropriate LICOR
IR secondary antibody. The membranes were washed again in the
same buffer and the bands were quantiﬁed using an IR-detection
LICOR Odyssey system.
2.4. Statistical analysis
Data in text, tables and ﬁgures are expressed as mean ± SEM or
median (interquartile range) where appropriate and in accordance
with accepted convention (n ¼ 15). Differences between pre- and
postoperative blood and muscle metabolites were determined us-
ing the Student's t test for paired samples (for parametric data) and
related samples Wilcoxon Signed Ranks Test (for non-parametric
data). The difference in 2 h post-prandial blood glucose concen-
tration between screening and 48 h postoperatively was deter-
mined using the Chi-square test. Differences were considered
signiﬁcant at P < 0.05.
3. Results
There were 15 participants (13 male) with a mean ± SEM age of
49.0 ± 4.5 yrs and body mass index of 26.0 ± 1.7 kg/m2. Sevenwere
operated for cancer and 8 for benign diseases, such as chronic
pancreatitis and large incisional herniae. Mean time elapsed be-
tween the start and the end of surgery was 223 ± 22 min (range
110e390 min).
3.1. Clinical and laboratory tests
Haemoglobin, blood urea and electrolytes, and liver function
tests measured during the screening visit were within the normal
laboratory ranges for all participants.
3.1.1. Blood glucose and plasma insulin, cytokines, cortisol and free
fatty acid concentrations
Table 1 shows that, according to the ranges suggested by the
World Health Organisation [16], signiﬁcantlymore participants had
higher fasting and post-prandial blood glucose concentrations
postoperativelywhen comparedwith the screening test (P< 0.001).
Compared with the screening visit, fasting plasma insulin con-
centrationwas signiﬁcantly lower at the start (P < 0.05) and the end
(P < 0.05) of surgery, but were no different 48 h postoperatively
(Table 2). Plasma IL-6 concentration was 15-fold greater at the end
of surgery compared with screening (P < 0.001) and remained
elevated 48 h postoperatively (P < 0.001, Table 2). Plasma TNF-a
concentration was also elevated 48 h postoperatively compared
with screening (P < 0.05; Table 2), but this difference was not of the
very large magnitude seen for plasma IL-6 concentration. Plasma
cortisol concentration was elevated 3.5-fold immediately after
surgery compared with screening (P < 0.001), but was no different
from screening 48 h postoperatively (Table 2). Plasma FFAiated muscle metabolic dysregulation local and remote to the site of
6/j.clnu.2017.10.020
Table 1
Fasting and 2 h post-prandial blood glucose concentration determined at the volunteer screening visit and 48 h postoperatively. Values represent the number of participants
falling into each blood glucose concentration range according to the WHO deﬁnition [16].
Blood glucose (mmol/L) Screening visit 48 h postoperatively
Fasting 2 h post-prandial Fasting 2 h post-prandial
<6.1 13 9 12 1
6.1 & <7.0 0 0 3 0
7.0 & <7.8 1 1 0 1
7.8 1 5 0 13
Screening vs. 48 h postoperatively P < 0.001; Chi-square test.
Table 2
Fasted plasma insulin, cytokines, cortisol and free fatty acids concentrations in patients undergoing major elective abdominal surgery at screening, at the start of surgery,
immediately after surgery and 48 h postoperatively (n ¼ 15).
Screening At start of surgery Immediately after surgery 48 h postoperatively
Insulin (mIU/L) 11.9 (8.3e18.4) 10.5 (5.5e15.4)* 7.0 (5.7e14.2)* 10.2 (6.0e18.3)
IL-6 (pg/mL) 3.4 (2.2e4.6) 3.12 (2.6e4.0) 21.8 (14.0e90.5)*** 31.7 (14.8e70.5)***
TNF-a (pg/mL) 13.0 (11.5e14.2) 13.5 (12.5e14.2) 13.5 (12.9e14.2) 14.6 (12.3e16.1)*
Cortisol (ng/mL) 1.8 (1.2e3.3) 2.1 (1.4e3.5) 8.1 (3.9e11.1)*** 2.9 (1.0e4.0)
Free fatty acids (mmol/L) 0.2 (0.1e0.3) 0.5 (0.3e0.7)* 0.6 (0.4e1.0)*** 0.4 (0.2e0.6)*
Data are expressed as median (interquartile range).
*P < 0.05; **P < 0.01; ***P < 0.001 signiﬁcantly different from screening.
K.K. Varadhan et al. / Clinical Nutrition xxx (2017) 1e84concentrationwas greater than at screening at all time-points, with
the difference being most apparent immediately after surgery (3-
fold, P < 0.001; Table 2).3.1.2. Gut permeability and blood bacterial DNA expression
Gut permeability was increased 48 h postoperatively compared
with the screening visit (Fig. 1A, P < 0.05). However, the presence of
bacterial DNA in blood was undetectable 48 h postoperatively
(Fig. 1B). Bacterial DNA was conﬁrmed to be present in the positive
control DNA (Fig. 1B), which was isolated from the Gram positive
wild-type strain SG38 and is known to be found in the gastroin-
testinal tract of humans.3.1.3. Glycogen and lactate content in rectus abdominis and vastus
lateralis muscles
Muscle glycogen and lactate content at the start of surgery and
immediately after surgery in RA and VA are presented in Table 3.
Following surgery, muscle glycogen content was less than that at
the start of surgery in RA (P < 0.05), while muscle lactate was
greater (P < 0.01). No differences were seen when comparing
muscle glycogen and lactate contents of the VL at the start of sur-
gery with those obtained at the end of surgery.3.1.4. mRNA expression levels in rectus abdominis and vastus
lateralis muscles
The mean change in mRNA abundance from the start of surgery
to immediately after surgery was sizeable for cathepsin-L (CSTL 1;
7.5-fold, P < 0.05), FOXO1 (10.5-fold, P < 0.05), MAFbx (11.5-fold,
P < 0.01), PDK4 (7.8-fold, P < 0.05) and TNF-a (16.5-fold, P < 0.05) in
RA (Fig. 2A). No change inmRNA abundance was recorded for Akt 1,
myostatin and IRS1 in RA. A similar pattern of change was observed
in the VL, albeit of a lowermagnitude, i.e. FOXO1 (2.5-fold, P< 0.05),
MAFbx (6.4-fold, P < 0.05), PDK4 (4.1-fold, P < 0.05) and TNF-a (5.8-
fold, P< 0.05; Fig. 2A), with no change in CSTL 1, myostatin, and IRS-
1 abundance being observed. IL-6 demonstrated the most striking
change in mRNA abundance from the start of surgery to immedi-
ately after surgery (1058- and 126-fold in the RA and VL, respec-
tively; Fig. 2B).Please cite this article in press as: Varadhan KK, et al., Inﬂammation-med
major abdominal surgery, Clinical Nutrition (2017), https://doi.org/10.1013.1.5. Targeted protein expression levels in rectus abdominis and
vastus lateralis muscles
At the end of surgery, protein expression levels of IL-6 (6-fold,
P < 0.01), MAFbx (4.5-fold, P < 0.05) and PDK4 (4-fold, P < 0.05) in
the RA were greater than at the start of surgery (Fig. 3A). No dif-
ference in protein abundance for the same proteins was recorded
between the start of surgery to immediately after surgery in VL
(Fig. 3B).4. Discussion
The major ﬁndings of the present study were that surgical
trauma induced a systemic inﬂammatory response immediately
after surgery that was accompanied by an increase in gut perme-
ability, but there was no evidence of bacteraemia or substantive
changes in fasting blood glucose or plasma insulin and cortisol
concentrations 48 h later. Post-prandial glucoregulation was,
however, impaired 48 h postoperatively. Immediately after surgery,
the abundance of mRNAs associated with tissue inﬂammation,
protein breakdown and impaired carbohydrate oxidation was
profoundly increased in muscle local to the site of surgical trauma
(RA), and was mirrored by similar pattern of mRNA response in
muscle distant to the site of injury (VL), albeit to a lesser extent.
These muscle gene responses were parallelled by changes at the
muscle protein level, and by lower muscle glycogen and elevated
muscle lactate concentrations, at the site local to surgical trauma,
but not in muscle away from the site of surgery. These ﬁndings
collectively demonstrate that a systemic postoperative inﬂamma-
tory response was accompanied by muscle inﬂammation and
metabolic dysregulation both local and remote to the site of sur-
gery, which is most marked at the site of surgery. These muscle
level responses, and not bacteraemia, likely contribute to the
impairment of muscle mass maintenance and systemic blood
glucose regulation in the days following surgery.
Postoperative hyperglycaemia is an important component of
post-operative complications and delayed recovery [17,18] and
arises as a result of decreased insulin-stimulated whole-body
glucose disposal as well as increased endogenous glucose release
[19]. Systemic inﬂammation has been reported to be an importantiated muscle metabolic dysregulation local and remote to the site of
6/j.clnu.2017.10.020
Fig. 1. A. Gut permeability in participants undergoing major abdominal surgery preoperatively and 48 h postoperatively (n ¼ 15), *P < 0.05. B. The presence of DNA representative of
Gram positive bacteria in circulating blood in participants 48 h postoperatively (n ¼ 15). The positive control comprised of DNA isolated from the Gram positive wild-type strain
SG38 of Bacillus subtilis, which is found in the gastrointestinal tract of humans.
K.K. Varadhan et al. / Clinical Nutrition xxx (2017) 1e8 5driver of insulin resistance (including muscle insulin resistance, the
largest contributor to whole-body glucose disposal) in ageing
[20,21], obesity [22,23], postoperative stress [22,24,25], and also in
muscle atrophy [20]. In keeping with this, a signiﬁcant correlation
between insulin resistance and plasma concentrations of IL-6 hasPlease cite this article in press as: Varadhan KK, et al., Inﬂammation-med
major abdominal surgery, Clinical Nutrition (2017), https://doi.org/10.101been reported in patients undergoing open cholecystectomy and
hernia repair [24], with only minor increments in the levels of
stress hormones postoperatively. On the other hand, based on
mRNA expression changes recorded in RA during major abdominal
surgery [4] it could be suggested that traumamediated induction ofiated muscle metabolic dysregulation local and remote to the site of
6/j.clnu.2017.10.020
Table 3
Glycogen and lactate content in rectus abdominis and vastus lateralis muscles at the start of surgery and immediately after surgery in patients undergoing major elective
abdominal surgery (n ¼ 15).
Metabolite Rectus abdominis muscle (local to the site of surgery) Vastus lateralis muscle (distant from the site of surgery)
At start of surgery Immediately after surgery At start of surgery Immediately after surgery
Glycogen (mmol/kg dry matter) 330 (300e361) 295 (275e320)* 341 (311e352) 337 (311e360)
Lactate (mmol/kg dry matter) 4.6 (3.4e5.6) 9.7 (8.9e11.2)** 5.5 (4.9e5.8) 5.98 (5.3e6.3)
Data are expressed as median (interquartile range).
*P < 0.05, **P < 0.01 signiﬁcantly different from value at the start of surgery.
Fig. 2. Fold change in (top) Akt1, Cathepsin-L (CSTL1), FOXO1, MAFbx, myostatin
(MSTN), PDK4, TNF-a and IRS1 mRNA expression and (bottom) IL-6 mRNA expression
in rectus abdominis (local to the site of surgery) and vastus lateralis (distant from the
site of surgery site) muscle obtained at the start of surgery and immediately after
surgery from participants undergoing major abdominal surgery (n ¼ 15). Values are
expressed as fold changes from the value at the start of surgery. *P < 0.05, **P < 0.01,
***P < 0.001, signiﬁcantly different from the value at the start of surgery.
K.K. Varadhan et al. / Clinical Nutrition xxx (2017) 1e86inﬂammatory pathways in skeletal muscle per se, rather than
circulating cytokines, may be an important driver of postoperative
insulin resistance. Indeed, Witasp et al. [4] demonstrated increased
expression of mRNAs encoding inﬂammation proteins such as IL-6
and TNF-a in skeletal muscle during major abdominal surgery.
Importantly, as far as we are aware no study has documented
muscle inﬂammatory mRNA and protein and tissue metabolic re-
sponses both locally and distant from the site of surgical trauma.
Here, we have shown that major abdominal surgery was associatedPlease cite this article in press as: Varadhan KK, et al., Inﬂammation-med
major abdominal surgery, Clinical Nutrition (2017), https://doi.org/10.101with elevated plasma IL-6, TNF-a and cortisol concentrations,
which persisted for 48 h in the case of IL-6 (Table 2). In tandemwith
this, mRNA expression of IL-6 and TNF-a was profoundly elevated
in RA (>1000 fold and >15 fold, respectively) and VL (~100 fold and
~6 fold, respectively) immediately after surgery compared with at
the start of surgery (Fig. 2). Based on these data, and in keeping
with the sentiment of Witasp et al. [4], one could reasonably
postulate postoperative impairment of blood glucose disposal is, at
least partly, attributable to the cytokine mediated impairment of
muscle glucose uptake. In line with this, Fig. 3 illustrates that the
increase in muscle mRNA abundance of IL-6 and PDK4 we observed
was parallelled by increased expression at the protein level in the
RA immediately after surgery. Increasing evidence suggests that
activation (dephosphorylation) of the FOXO family of transcription
factors plays an important part in triggering the inhibition of
muscle carbohydrate oxidation in metabolic stress situations, at
least in part, through transcriptional upregulation of its down-
stream target PDK4, and consequently decreased PDC activation
and ﬂux (the rate-limiting step in the carbohydrate oxidation),
thereby resulting decreased oxidative glucose utilisation and
elevated tissue glycogen use and lactate content [26,27]. Further-
more, we have previously provided substantive evidence of muscle
cytokine accumulation mediating these events during LPS-induced
endotoxaemia in rodents [10,12,28], and in critically-ill patients
[29]. Importantly, the postoperative elevation in muscle IL-6 and
PDK4 protein content in RA was accompanied by reduced muscle
glycogen and muscle lactate contents (Table 3), strongly suggesting
the induction of muscle metabolic dysregulation at this time point.
Given that a similar, albeit less marked, muscle response was
observed in the VL postoperatively, it is plausible that this may have
resulted in similar metabolic and protein changes over the course of
48 h postoperative recovery to those observed in the RA immedi-
ately after surgery. We, therefore, speculate that muscle-speciﬁc
inﬂammation and metabolic dysregulation, particularly local to
the site of surgery, may be contributing to the well documented
impaired glucoregulation in the days following surgery. Impor-
tantly, although these changes were accompanied by an increase in
postoperative gut permeability, we found no evidence of bacter-
aemia 48 h postoperatively, making it unlikely that bacterial
translocation across the gut contributed to the systemic or muscle
level responses we have reported.
Cytokines also inﬂuence skeletal muscle protein catabolism by
directly modulating protein synthesis and degradation and indi-
rectly, through inhibition of the action of regulatory anabolic hor-
mones [30] and activation of hypothalamicepituitaryeadrenal axis
[31]. In keeping with this, we have previously shown that muscle
inﬂammation induced atrophy during LPS-induced endotoxaemia
in rodent skeletal was tightly coupled to the upregulation of the
FOXO downstream targets MAFbx, MuRF1, 20S proteasome and
cathepsin-L at both mRNA and protein levels [10,12], and a similar
pattern of events also evident in the muscle of intensive care pa-
tients [29]. The muscle speciﬁc E3-ubiquitin ligases MAFbx and
MuRF1 [32], are considered to be key regulators of ubiquitin pro-
teasome mediated muscle protein degradation [6], and areiated muscle metabolic dysregulation local and remote to the site of
6/j.clnu.2017.10.020
Fig. 3. Relative protein expression levels of IL-6, MAFbx, PDK4, the ratio of Pp70S6K/p70S6K and the ratio of PFOXO1/FOXO1 in (top) rectus abdominis muscle (local to the site of
surgery) and (bottom) vastus lateralis muscle (distant from the site of surgery) obtained at the start of surgery and immediately after surgery from participants undergoing major
abdominal surgery (n ¼ 15). Values are expressed as fold change from the value at the start of surgery. *P < 0.05, **P < 0.01 signiﬁcantly different from the value at the start of
surgery (set at 1).
K.K. Varadhan et al. / Clinical Nutrition xxx (2017) 1e8 7dampened using anti-inﬂammatory interventions [10,11]. In
keeping with this, we were also able to show substantial upregu-
lation of MAFbx mRNA (Fig. 2) in RA and VL immediately after
surgery, which was accompanied by increase protein expression in
the RA (Fig. 3). Again, despite evidence of increased gut perme-
ability 48 h postoperatively (Fig. 1A), these muscle level changes
immediately after surgery were not supported by the presence of
bacteraemia 48 h later (Fig. 1B), suggesting once more that muscle
level inﬂammation secondary to surgical stress was driving cellular
events and upregulating muscle protein breakdown.
Surgical stress was associated with increased mRNA expression
of FOXO1 in RA and VL and several FOXO gene targets (Fig. 2).
However, the ﬁnding that FOXO1 protein phosphorylation was not
decreased relative to at the start of surgery, particularly in the RA,
was unexpected (Fig. 3). There is no obvious explanation for this
observation given the increased expression of both PDK4 and
MAFbx protein in the RA, one explanation is the increase in RAPlease cite this article in press as: Varadhan KK, et al., Inﬂammation-med
major abdominal surgery, Clinical Nutrition (2017), https://doi.org/10.101cytokine protein expression mediated effects on FOXO downstream
targets via FOXO3 phosphorylation, rather than FOXO1. LPS induced
increases in muscle cytokines has been shown to be parallelled by
decreased cytosolic FOXO1 and FOXO3 phosphorylation in rodent
endotoxaemia [12].
To conclude, surgical trauma induced a systemic proin-
ﬂammatory cytokine response immediately after surgery that was
accompanied by an increase in gut permeability, but there was no
evidence of bacteraemia 48 h later. This systemic inﬂammatory
response to surgical trauma, in the absence of bacteraemia or
sepsis, was accompanied by profound muscle cytokine mRNA re-
sponses and metabolic dysregulation immediately post-surgery,
particularly local to the site of surgical trauma, which was consis-
tent with the impairment of post-prandial glucoregulation recor-
ded 48 h postoperatively. Collectively, these ﬁndings suggest that
muscle level responses, but not the presence of bacteraemia, likely
contribute to the impairment of muscle mass maintenance andiated muscle metabolic dysregulation local and remote to the site of
6/j.clnu.2017.10.020
K.K. Varadhan et al. / Clinical Nutrition xxx (2017) 1e88systemic blood glucose regulation in the days following major
abdominal surgery.
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